The efficacy and safety of targeted agents approved for advanced non-small cell lung cancer in China: a cross-sectional analysis
Background: Lung cancer, as the disease with the highest mortality and incidence rate in China, has emerged as one of the most heavily burdened diseases. Recently, China has approved several targeted cancer agents for advanced first-line non-small cell lung cancer (NSCLC), including small molecule d...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606524004383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|